Sawsan A Mohammed | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Sawsan A Mohammed | AI in Healthcare | Best Researcher Award

Assistant Professor at Clinical Education Qatar University, Qatar

Dr. Sawsan Gholam A. A. Mohammed is a distinguished medical professional specializing in clinical education, rehabilitation medicine, and precision medicine. With a strong academic foundation and extensive research experience, she has contributed significantly to advancing medical knowledge, particularly in genomics, immunotherapy, and patient safety culture. Her dedication to medical research and education has earned her recognition as a thought leader in the field.

Profile

Orcid

Education

Dr. Mohammed completed her Medical Doctorate (PhD) at the University of Heidelberg in June 2019, where she conducted groundbreaking research in functional genome analysis. She obtained her Doctor of Medicine (M.D.) from the Arabian Gulf University, Bahrain, in December 1997, and earlier earned a Bachelor of Basic Medical Science (BBMS) from the same institution in April 1996. Her educational background has provided her with a strong foundation in both clinical and research-oriented medical sciences.

Experience

Dr. Mohammed currently serves as an Assistant Professor at the Clinical Academic Education Department at the College of Medicine, Doha, Qatar, where she has been shaping the next generation of medical professionals since January 2023. Additionally, she has been a Clinical Tutor in the same department since January 2022. Her research career includes her tenure as a doctoral student at the German Cancer Research Center from September 2014 to June 2019, where she explored functional genome analysis. Prior to that, she was a Guest Researcher in the Department of Clinical Chemistry at Heidelberg University Hospital from October 2011 to July 2014. Her clinical expertise spans multiple roles, including Clinical Associate at Rumailah Hospital’s Physical Medicine & Rehabilitation Department (2008–2011), Clinical Trainee at Danderyds Hospital, Karolinska Institute, Sweden (2003–2008), and Resident Physician at Rumailah Hospital (2001–2003). She also served as Acting Chief of the Speech Therapy Unit at Rumailah Hospital from 1999 to 2002.

Research Interests

Dr. Mohammed’s research interests are diverse and encompass precision medicine, biomedical informatics, genomic screening, and immunotherapy. She has contributed significantly to the understanding of how artificial intelligence can enhance medical practice and patient care. Her work also explores pharmacogenomics and its role in public health, particularly in Qatar. Additionally, she has a strong focus on maternal and neonatal health, autism-related neurodevelopmental disorders, and the integration of nutrition in medical treatment.

Awards and Recognitions

Dr. Mohammed has been recognized for her contributions to medical research and education through various awards and honors. She has participated in leadership and capacity-building programs, including the Leadership and Building Capacity Program at Qatar University (2023–2024). Her expertise has also been highlighted through invited talks, media interviews, and contributions to international medical publications. Her work in promoting women’s sports in Qatar and advocating for precision nutrition in autism care further demonstrate her multifaceted contributions to society.

Selected Publications

“Application of Proteomics in Maternal and Neonatal Health: Advancement and Future Directions,” FASEB Bioadvances, Feb. 2025.

“Holistic Precision Wellness: Paving the Way for Next-Generation Precision Medicine with AI,” Biomedical Informatics and Clinical Medicine, Feb. 2025.

“Ṯābit Ibn Qurrah’s Contributions to Toxicology,” Naunyn Schmiedebergs Arch Pharmacol, Aug. 2024.

“Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes,” MDPI Cancers, May 2024.

“Optimizing Cancer Therapy: A Review of Metronomic Chemotherapy,” Frontiers in Cell and Developmental Biology, May 2024.

“Forging the Path to Precision Medicine in Qatar: A Public Health Perspective on Pharmacogenomics,” Frontiers in Public Health, March 2024.

“Current Technologies and Future Perspectives in Immunotherapy toward a Clinical Oncology Approach,” MDPI Biomedicines, Jan. 2024.

Conclusion

Dr. Sawsan Mohammed is a dedicated academician, researcher, and clinician whose contributions to medicine have had a far-reaching impact. Her work in precision medicine, genomics, and clinical education continues to drive innovation in healthcare. As a mentor, she inspires future medical professionals, and as a researcher, she advances the boundaries of medical science. Through her interdisciplinary approach and commitment to improving patient care, she remains a vital contributor to the global medical community.

Neeraj Thakur | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Dr. Neeraj Thakur | AI in Healthcare | Best Researcher Award

Postdoctoral Fellow at University of Oklahoma Health Sciences, United States

Dr. Neeraj S. Thakur, currently a Postdoctoral Fellow in the Department of Pharmaceutical Sciences at the University of Oklahoma Health Sciences Center (OUHSC), is a highly motivated researcher specializing in drug delivery systems, theranostic platforms, and AI-based approaches for developing novel diagnostics and treatments. With over a decade of international research experience spanning the USA, Europe, and Asia, Dr. Thakur has led multiple projects related to nanomaterial design, formulation development, and the synthesis of advanced drug delivery systems for treating diseases like cancer and infections. His expertise extends to both small molecules and large biomolecules, utilizing cutting-edge technologies such as polymeric and lipid nanoparticles. He has an extensive publication record with 29 papers, five patents, six book chapters, and significant contributions to the field.

Profile

Scopus

Education

Dr. Thakur earned his Ph.D. in Pharmaceutical Technology (Biotechnology) from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India, where his research focused on the development of nanoparticle-based fluorescent probes for biomedical applications. He also holds an M.Tech in Pharmaceutical Technology (Biotechnology) from NIPER, Mohali, where he was the class topper, and a B.Pharm degree from Shri G.S. Institute of Technology and Science, Indore. Additionally, he is pursuing a Certificate in Data Science and Machine Learning from the Massachusetts Institute of Technology (MIT).

Experience

Dr. Thakur has held significant roles in various research institutions. As a Postdoctoral Fellow at OUHSC, he established research laboratories and led projects on nanomaterial development for drug delivery systems targeting multiple applications, including inner ear and ocular delivery. Prior to this, he worked at the University of Geneva, Switzerland, where he developed hybrid micelle formulations for transdermal delivery and designed iontophoretic devices. He also contributed to the Center of Innovative and Applied Bioprocessing (CIAB), India, where he led the development of topical drug delivery systems and was involved in several patent filings. These experiences have honed his skills in formulation and analytical development, laboratory management, and industrial collaboration.

Research Interests

Dr. Thakur’s research interests focus on the development of advanced drug delivery systems, particularly using nanomaterials such as polymeric and lipid nanoparticles. His work aims to improve the therapeutic efficacy of drugs by enhancing their delivery to specific sites in the body, such as the inner ear, ocular tissues, and tumors. He is also dedicated to the integration of AI-based approaches for optimizing drug delivery design, ensuring more precise treatments for conditions like cancer and ototoxicity. His passion extends to the creation of theranostic platforms for early disease diagnosis and personalized medicine.

Awards

Throughout his career, Dr. Thakur has received numerous accolades for his contributions to pharmaceutical sciences. Notable among them are the John B. Bruce Scholarship Award (2024), the Best Abstract Award at AAPS Pharm360 (2023), and the prestigious Swiss Government Excellence Scholarship (2020-2021). His earlier achievements include the DST-INSPIRE and CSIR Research Fellowships, which are awarded to the top 1% of students in India. These recognitions underscore his impact on the scientific community and his leadership in advancing pharmaceutical research.

Publications

Dr. Thakur has authored 29 peer-reviewed papers, with some of his recent work focused on innovative drug delivery systems. Key publications include:

Thakur, N.S., et al., “Crosslinked Hybrid Nanoparticle Embedded in Thermogel For Sustained Co-Delivery to Inner Ear,” Journal of Nanobiotechnology, 2024.

Thakur, N.S., et al., “Progress and Promise of Photoresponsive Nanocarriers for Precision Drug Delivery in Cancer,” Journal of Photochemistry & Photobiology C: Photochemistry Reviews, 2024.

Thakur, N.S., et al., “Dual Stimuli-Responsive and Sustained Drug Delivery Nanosensogel for Prevention of Cisplatin-Induced Ototoxicity,” Journal of Controlled Release, 2024.

Paul, S., et al., “Co-Administration of Chemo-Phototherapeutic Loaded Lignin Nanoarchitecture for Skin Cancer and Bacterial Infections,” ACS Applied Nano Materials, 2024.

Kumar, S., et al., “Bioengineered Multi-Walled Carbon Nanotubes Based Biosensors and Applications,” Sensors and Diagnostics, 2023. These works, which cover nanomedicine, drug delivery, and nanomaterial innovation, have significantly contributed to the field of pharmaceutical sciences and have been widely cited.

Conclusion

Dr. Neeraj S. Thakur’s multifaceted career highlights his dedication to advancing pharmaceutical research through innovation in nanotechnology and drug delivery systems. His profound knowledge in both academic and industrial settings, along with his leadership in driving collaborative research projects, continues to position him as a key figure in his field. With a focus on precision medicine, AI-based design, and the development of targeted therapies, Dr. Thakur is making remarkable strides toward improving patient outcomes and advancing the future of drug delivery and diagnostics.